床旁高敏心肌肌钙蛋白I早期诊断心肌梗死的临床性能
本研究纳入急诊疑似心肌梗死患者1261例,以中心实验室高敏肌钙蛋白为参照,评估床旁高敏肌钙蛋白I检测(POC-hs-cTnI-TriageTrue)的诊断准确性,并推导验证其0/1小时算法。结果显示该床旁检测AUC为0.95,与中心实验室检测至少相当,0/1小时算法可安全排除55%患者(阴性预测值100%)。
要点
- 床旁hs-cTnI诊断准确性高,AUC 0.95,与中心实验室检测至少相当。
- 单次 cutoff <3 ng/L可识别45%低危患者,阴性预测值100%。
- 0/1小时算法排除55%患者,阴性预测值100%,30天事件率0%。
核心结论
- 床旁hs-cTnI-TriageTrue在疑似心梗患者中诊断准确性高,临床性能至少与最佳验证的中心实验室检测相当。
研究设计与样本
- 前瞻性队列研究,纳入急诊疑似心梗患者1261例,最终心梗确诊178例(14%),由两名心内科医师中心裁定诊断。
主要发现
- 床旁hs-cTnI就诊时AUC为0.95(95%CI 0.93-0.96),与hs-cTnT-Elecsys的AUC 0.94(95%CI 0.93-0.96;p=0.213)至少相当,优于hs-cTnI-Architect的AUC 0.92(95%CI 0.90-0.93;p<0.001)。
- 单次cutoff <3 ng/L识别45%低危患者,阴性预测值100%(95%CI 99.4%-100%)。
- 单次cutoff >60 ng/L识别高危患者,阳性预测值76.8%(95%CI 68.9%-83.6%)。
- 0/1小时算法排除55%患者(阴性预测值100%;95%CI 98.8%-100%),纳入18%患者(阳性预测值76.8%;95%CI 67.2%-84.7%)。
- 被排除患者30天累积事件率0%,2年累积事件率1.6%。
关键数值与推荐
- 床旁hs-cTnI-TriageTrue特异性0/1小时算法中,排除阈值为就诊时<3 ng/L,纳入阈值为就诊时>60 ng/L。
临床怎么用
- 床旁hs-cTnI-TriageTrue可快速提供高精度检测结果,其0/1小时算法有助于急诊疑似心梗患者的快速分诊。
局限性
- 本文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for large central laboratory platforms. OBJECTIVES: This study aimed to assess the clinical performance of a point-of-care (POC)-hs-cTnI assay in patients with suspected myocardial infarction (MI). METHODS: This study enrolled patients presenting to the emergency department with symptoms suggestive of MI. Two cardiologists centrally adjudicated the final diagnosis using all clinical data including cardiac imaging. The primary objective was to directly compare diagnostic accuracy of POC-hs-cTnI-TriageTrue versus best-validated central laboratory assays. Secondary objectives included the derivation and validation of a POC-hs-cTnI-TriageTrue-specific 0/1-h algorithm. RESULTS: MI was the adjudicated final diagnosis in 178 of 1,261 patients (14%). The area under the curve (AUC) for POC-hs-cTnI-TriageTrue at presentation was 0.95 (95% confidence interval [CI]: 0.93 to 0.96) and was at least comparable to hs-cTnT-Elecsys (AUC: 0.94; 95% CI: 0.93 to 0.96; p = 0.213) and hs-cTnI-Architect (AUC: 0.92; 95% CI: 0.90 to 0.93; p < 0.001). A single cutoff concentration <3 ng/l at presentation identified 45% of patients at low risk with a negative predictive value (NPV) of 100% (95% CI: 99.4% to 100%). A single cutoff concentration >60 ng/l identified patients at high risk with a positive predictive value (PPV) of 76.8% (95% CI: 68.9% to 83.6%). The 0/1-h algorithm ruled out 55% of patients (NPV: 100%; 95% CI: 98.8% to 100%), and ruled in 18% of patients (PPV: 76.8%; 95% CI: 67.2% to 84.7%). Ruled-out patients had cumulative event rates of 0% at 30 days and 1.6% at 2 years. This study confirmed these findings in a secondary analysis including hs-cTnI-Architect for central adjudication. CONCLUSIONS: The POC-hs-cTnI-TriageTrue assay provides high diagnostic accuracy in patients with suspected MI with a clinical performance that is at least comparable to that of best-validated central laboratory assays. (Advantageous Predictors of Acute Coronary Syndromes Evaluation Study [APACE]; NCT00470587).
引用
- Boeddinghaus J, Nestelberger T, Koechlin L, et al. Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I. J Am Coll Cardiol. 2020. PMID: 32164884. doi:10.1016/j.jacc.2019.12.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。